FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials
Alessandro Mantovani, Herbert Tilg, Giovanni Targher
Topics & Concepts
SteatohepatitisPlaceboMedicineInternal medicineGastroenterologyFibrosisMeta-analysisFatty liverSurgeryPathologyDiseaseAlternative medicineFibroblast Growth Factor ResearchLiver Disease Diagnosis and TreatmentPancreatitis Pathology and Treatment